Why Invest

We develop products and solutions that make life better – and have been successfully doing so for over 300 years. And when you’ve prospered for centuries as we have, you must have done a few things right.

It’s a great idea to invest in us – and here’s why

Related News

View All News
  1. Press Releases

    Merck KGaA, Darmstadt, Germany, Strengthens Oncology Portfolio Through Commercialization ...

    Merck KGaA, Darmstadt, Germany, today announced a license agreement with Abbisko Therapeutics for pimicotinib (ABSK021).

    2023/12/04

  2. Press Releases

    Together with p-Chip we close the gap between physical and digital trust layers

    We successfully integrated p-Chip's microtransponder technology as a crypto-anchor into a cyber-physical trust framework solution developed by us.

    2023/11/28

  3. Press Releases

    MilliporeSigma Expands Newest Biologics Testing Center in Shanghai

    Further develops its biosafety testing laboratories for local demand; New labs complete 2nd phase of company's €29 million Biologics Testing Center.

    2023/11/21

investors-shareprice2 investors-shareprice2
Share Price
Check Share Price
Share Price
Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.
453077651 453077651
Financials
Read More
Financials
Our Financial Reporting Center offers you the opportunity to select from financial data on an annual or quarterly basis.